Diabetic kidney disease: a report from an ADA Consensus Conference.
about
Management of anemia in patients with diabetic kidney disease: A consensus statementTregs and kidney: From diabetic nephropathy to renal transplantationImprovements in the Management of Diabetic NephropathyMeta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on AlbuminuriaEffectiveness of management models for facilitating self-management and patient outcomes in adults with diabetes and chronic kidney diseaseGenome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.Effects of sodium-glucose co-transporter 2 (SGLT2) inhibition on renal function and albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis.MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathyEfficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis.Association of Thyroid-Stimulating Hormone Levels with Microvascular Complications in Type 2 Diabetes Patients.Diet and Diabetic Kidney Disease: Plant Versus Animal Protein.Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort studyAnalysis and Quantitation of Glycated Hemoglobin by Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry.Nutrition Intervention for Advanced Stages of Diabetic Kidney Disease.Hypertension Management in Diabetic Kidney DiseaseMouse Models of Diabetes, Obesity and Related Kidney Disease.Epidemiology of chronic kidney diseases in the Republic of Guinea; future dialysis needsComparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis.Effectiveness of mHealth interventions for patients with diabetes: An overview of systematic reviews.Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.Association of 2184AG Polymorphism in the RAGE Gene with Diabetic Nephropathy in Chinese Patients with Type 2 Diabetes.Prostaglandin I2 Receptor Agonism for Proteinuria and Diabetes: Good for the Goose and Good for the Gander?Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes.Additive Effect of Qidan Dihuang Grain, a Traditional Chinese Medicine, and Angiotensin Receptor Blockers on Albuminuria Levels in Patients with Diabetic Nephropathy: A Randomized, Parallel-Controlled Trial.Renal PET-imaging with (11)C-metformin in a transgenic mouse model for chronic kidney disease.Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial.An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease.Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial.Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients.Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials.Haemodialysis-induced hypoglycaemia and glycaemic disarrays.Treating posttransplantation diabetes mellitus.Future research directions to improve fistula maturation and reduce access failure.Teneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario.Managing blood glucose levels in patients with diabetes and renal impairment.Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.Cultural Sensitivity and Challenges in Management of the Transgender Patient With ESRD in Transplantation.Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study.A systematic review of the benefits and harms of dipeptidyl peptidase-4 inhibitor for chronic kidney disease.
P2860
Q26752692-ADD13819-0CC3-4A03-9282-D75A9A032CD9Q28066728-7B085321-00C7-4B21-909C-C4225F84F24FQ28080717-7CC13D12-813C-4BE3-85AF-D266A406B3C1Q28085248-9397DF45-63FC-4BAE-B6B5-B6CA6BAF1A18Q28086936-D19CD428-5E3D-4612-A3C4-1484C22E6742Q30353876-D96B93B5-736E-4EB7-BEE1-B729212AC420Q31107244-4E865F9E-D97D-4872-97A1-D94931AD7B7CQ32186373-AB046D86-7FDA-4302-A7FE-1BDAB1F435C9Q33653982-B6453F20-470B-4B2E-ADF2-1559C81220B7Q33687578-B4734006-A4A5-4E83-8110-B3259C3A92A0Q33787864-408E11D7-8115-4996-BC0E-7BF526D84EBCQ33889472-002A0999-D78B-4A8F-B03E-A65017E11DD5Q33901411-F83DDF9D-BD6D-49E3-B4A1-426D955D53C9Q35886251-B2A19778-D428-401A-B84B-166E70EF39AAQ35953877-356CAB0D-1768-4F39-8CFB-6D03FD0D25D6Q35953909-0632D1C7-8ADF-4F0D-BE6C-BDF4C17FA2CDQ36118363-B64B3BE2-6D3E-4F55-B1D8-1184746E388DQ36130817-277EB6AD-5466-42A8-8047-BE493CC6A0D9Q36237809-D94B185C-11BD-4396-9897-A08308DD13A6Q36294089-BF48B242-4DAB-4B36-9240-D064430E74C6Q36326815-F6E18C23-29D9-4BD1-BC15-72DF90F1F997Q36378760-42C077DA-D3B0-49D9-9C2A-A48E9B8C6A1FQ36820725-6AD3C29D-95F2-4DA7-BF95-5C9C9083496BQ37018458-82D71DD8-B608-48A7-8942-1FEBBAA9FF5FQ37027123-AB20A71A-69E1-496A-8E70-ADD7C4F74607Q37034003-D017BD00-8A18-4FF7-9CF1-C01C179486D0Q37133956-671354BC-8417-44E9-8802-301F9900A8A2Q37141607-E150B977-CCD7-4018-A9B0-E0E671FDAE35Q37178054-5D54A208-172F-4601-8980-3D2A28A2B71AQ37689847-6C68694C-3FB8-4606-8F4A-5522A80CA915Q37696496-B2D9804A-6ED8-4217-8377-F5FCE47B979CQ38409082-5CB658CE-D9B1-4A4B-B8C5-EBE9563B5674Q38441421-9D001C45-DBD3-440C-B3F2-42F5E5BFC11EQ38646515-7A87DE0B-B648-4D94-A3F1-A40E3109AF2FQ38648862-6092215B-08F6-4C0D-8BA2-C6150CA6D3BEQ38745669-8BD91C8E-612D-48B5-B7A7-6397B2AE154DQ38746316-965275D2-9EE7-4B9D-9D2E-D196A12F995BQ38823111-8F60DFEF-B3C1-42FF-8ED5-C126D7DD4DA9Q38865432-1309B250-1596-4C6A-949D-05326B94FACAQ38902615-AA270878-CA43-410A-8438-8B34A9054938
P2860
Diabetic kidney disease: a report from an ADA Consensus Conference.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Diabetic kidney disease: a report from an ADA Consensus Conference.
@en
type
label
Diabetic kidney disease: a report from an ADA Consensus Conference.
@en
prefLabel
Diabetic kidney disease: a report from an ADA Consensus Conference.
@en
P2093
P1476
Diabetic kidney disease: a report from an ADA Consensus Conference.
@en
P2093
Andrew S Narva
George L Bakris
Ian H de Boer
Irl B Hirsch
Jane L Chiang
Jordi Goldstein-Fuchs
Joshua J Neumiller
Katherine R Tuttle
Mark E Molitch
Robert E Ratner
P304
P356
10.1053/J.AJKD.2014.08.001
P577
2014-10-01T00:00:00Z